Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-27KYMR3Power of Attorney for Terence Rooney
This filing details a Limited Power of Attorney granted by Terence Rooney, Chief Medical Officer of Kymera Therapeutics, Inc., to Nello Mainolfi, Bruce Jacobs, and William D. Collins. The power of attorney authorizes the appointed individuals to execute SEC filings on behalf of Mr. Rooney, including Forms 3, 4, and 5, ...
Mid CapBiotechnology
2026-07-27KLRS3Power of Attorney for Amy VandekopMEDIUM
This filing details a Power of Attorney granted by Amy Vandekop, an officer of Kalaris Therapeutics, Inc., to Andrew Oxtoby and Liisa Bayko. The attorneys-in-fact are authorized to act on Ms. Vandekop's behalf regarding SEC filings, including executing and submitting Forms 3, 4, 5, Schedules 13D and 13G, and Forms 144....
Micro CapBiotechnology
2026-07-24APLM3Initial Statement of Beneficial Ownership - Apollomics Inc.MEDIUM
This filing is an Initial Statement of Beneficial Ownership for Apollomics Inc. (APLM), filed by Yen Hung Hsien, a director. The filing is in connection with the Holding Foreign Insiders Accountable Act. On July 20, 2026, Yen Hung Hsien was granted 500 restricted stock units, which are set to vest on September 15, 2026...
Nano CapBiotechnology
2026-07-24BRTX3BioRestorative Therapies, Inc. - Officer/Director Change Filing
This filing reports a change in director at BioRestorative Therapies, Inc. Steven Collier Brown, who is a director, has signed the document on July 24, 2026, related to the reporting period of July 14, 2026. The filing indicates that Mr. Brown holds no securities in the company, as noted by "noSecuritiesOwned": "1". Th...
Nano CapBiotechnology